Delivery Order SPE2DB22D3301-SPE2DB24FY1TX
Award Date
3/1/24
Potential Completion Date
3/22/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,071,825 units of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The delivery order, valued at $3,518.40, has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, which...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a ceiling value of $3,518.40 and a performance period through May 3, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
This is a $7,641.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of NUBEQA 300 MG TABLET 120S, a prescription medication. It has an ultimate completion date of April 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract does not mention any major...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $3,518.40 order is for the supply of 120 tablets of the pharmaceutical product NUBEQA 300 MG. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
This federal contract award, valued at $7,641.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 3, 2025. The contract is for the supply of the drug NUBEQA 300 MG TABLET 120S. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 120 tablets of the pharmaceutical product NUBEQA 300 MG. The potential value of this delivery order is $14,073.60, with a completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and this contract does not have a set-aside designation. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the delivery of 120 tablets of the prescription medication NUBEQA 300 mg. The contract has an ultimate completion date of March 14, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business category....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of global pharmaceutical distributor Amerisourcebergen Corporation, to provide 120 tablets of the drug NUBEQA 300 MG. The $3,518.40 delivery order, which has a completion date of January 29, 2024, supports DLA Troop Support Medical's provision of pharmaceuticals and critical care supplies for military treatment programs and facilities. No set-aside designation was used...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order for the supply of NUBEQA 300 MG TABLET 120S to the Defense Logistics Agency (DLA). The contract has a potential value of $7,036.80 and a completion date of March 14, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $3,518.40, is for the supply of the prescription drug NUBEQA 300 MG TABLET 120S. The contract has a completion date of May 20, 2024 and is a firm fixed price, delivery order type contract. This contract is not set aside for any socioeconomic program. Amerisourcebergen Drug Corp is a subsidiary of the parent company...